Two Sigma Securities’s GT Biopharma GTBP Stock Holding History

Two Sigma Securities’s Portfolio GTBP Stock Details GTBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.55K	Sell	13,386 -18,410	-58%	-$7.47K	﹤0.01%	1580
2026 Q1	$13K	Buy	31,796 +19,262	+154%	+$10.5K	﹤0.01%	1440
2025 Q4	$9.84K	Sell	12,534 -4,531	-27%	-$3.22K	﹤0.01%	1291
2025 Q3	$10K	Buy	+17,065	New	+$25.5K	﹤0.01%	1217
2024 Q1	–	Sell	-1,239	Closed	-$9.48K	–	3211
2023 Q4	$9.48K	Buy	1,239 +207	+20%	+$1.51K	﹤0.01%	2823
2023 Q3	$7.46K	Buy	+1,032	New	+$8.53K	﹤0.01%	2741

Other funds holding GTBP

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

EFG

Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return

AAP

Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return

OWA

Opal Wealth Advisors Jericho, New York $463M AUM 20.47% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

4WM

49 Wealth Management Austin, Texas $524M AUM 16.59% 1-Year Est. Return

Alongside Austin, Texas $525M AUM

Two Sigma Securities's GTBP Position: Q2 2026 in Review

Two Sigma Securities reduced its GT Biopharma (GTBP) stake by 58% in Q2 2026, selling an estimated $7.47K and leaving 13,386 shares worth $6.55K. The position accounts for ﹤0.01% of the portfolio, ranked #1580.

Two Sigma Securities first reported a position in GTBP in Q3 2023 and has held it in 6 quarters since. The position peaked at $13K in Q1 2026. 59 funds tracked by Wall St. Rank hold GTBP as of Q2 2026.

Two Sigma Securities held 13,386 shares of GT Biopharma worth $6.55K as of Q2 2026.
Two Sigma Securities sold 18,410 GT Biopharma shares in Q2 2026, an estimated $7.47K.
GT Biopharma made up ﹤0.01% of Two Sigma Securities's portfolio in Q2 2026, its #1580 holding.
Two Sigma Securities first reported a position in GT Biopharma in Q3 2023 and has held it in 6 quarters since.
Two Sigma Securities's GT Biopharma position peaked at $13K in Q1 2026.
59 funds tracked by Wall St. Rank held GT Biopharma as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.